CClinicalTrials.gg
CompletedNCT04561596Updated Sep 30, 2022

Virtually Augmented Self Hypnosis in Peripheral Vascular Interventions

An interventional study of OnComfort autohypnosis and Treatment as usual, without the OnComfort autohypnosis system in Anxiety Postoperative, Pain, Postoperative and Vascular Access Site Pain, sponsored by Salah D. Qanadli, MD, PhD. Completed at 1 site in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-09-30.

Sponsored by Salah D. Qanadli, MD, PhD · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of our study is to compare patients anxiety and pain during percutaneous vascular interventions with and without virtual reality autohypnosis.

Read the detailed description

The participants in the control group will be treated under local anesthesia, following the usual care protocols.

The participants in the experimental group will be treated under the same conditions, except that they will experience virtual reality autohypnosis during the intervention.

02

Conditions studied

  • Anxiety Postoperative
  • Pain, Postoperative
  • Vascular Access Site Pain

Browse trials for

Keywords

  • Anxiety
  • Pain
  • Virtual reality
  • Virtual reality autohypnosis
  • Hypnosis
  • Non-pharmacological approaches
03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 100 is above the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

This is the only study on the registry with Salah D. Qanadli, MD, PhD as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Informed consent as documented by signature
  • > 18 years
  • Any indication for a percutaneous vascular interventional with a single vascular access (angiography, phlebography, arterial intervention, venous intervention) planned to be done under local anesthesia

Exclusion criteria

Exclusion Criteria:

  • No French language comprehension, deaf or visually impaired patient
  • Inability to sign informed consent
  • Need of sedative medication
  • History of motion sickness
  • History of psychiatric disease such as paranoia, schizophrenia, deep water phobia and dementia
  • Patient does not tolerate the virtual reality mask during the pre operative visit at Day 1
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Autohypnosis

    Use of virtual reality with head mounted display

    Device: OnComfort autohypnosis

  • Other
    Control

    Treatment as usual

    Other: Treatment as usual, without the OnComfort autohypnosis system

Interventions

  • DeviceOnComfort autohypnosis

    Participant arrive in our day care clinic and is prepared as any other patient in interventional radiology. The investigator will collect the signed informed consent form and proceed to randomization. The participant will then fill the pre and post-operative anxiety and pain questionnaire. The percutaneous vascular procedure will be performed as usual except for the virtual reality mask and autohypnosis software that will run during the whole intervention. Pain and anxiolytic medication are provided if needed during the intervention. Immediately after the intervention, the participant will fill the post-operative anxiety and pain questionnaire. The participant will be instructed to report anxiety and pain felt during the intervention. A clinical visit at 3 month is conducted as part of the standard clinical protocol. The participant will fill a 3rd questionnaire about the remembered anxiety and pain during the intervention.

  • OtherTreatment as usual, without the OnComfort autohypnosis system

    The Participant arrive in our day care clinic and is prepared as any other patient in interventional radiology. The investigator will collect the signed informed consent form and proceed to randomization. The participant will then fill the pre and post-operative anxiety and pain questionnaire. The percutaneous vascular procedure will be performed as usual. Pain and anxiolytic medication are provided if needed during the intervention. Immediately after the intervention, the participant will fill the post-operative anxiety and pain questionnaire. The participant will be instructed to report anxiety and pain felt during the intervention. A clinical visit at 3 month is conducted as part of the standard clinical protocol. The participant will fill a 3rd questionnaire about the remembered anxiety and pain during the intervention.

06

What researchers measure

Primary outcomes

  1. Per procedural anxiety.

    Per procedural anxiety, measured by the Spielberger Anxiety State Inventory in French (Gauthier and Bouchard, 1993). The Spielberger Anxiety State Inventory is a self questionnaire of 20 items, each item scores from 1 to 4. The result of the test is the sum of the 20 items, therefore the result ranges from 20 to 80. A high score is related to a high level of anxiety at the moment of the test.

    Time frame: Day 1 (Immediately after the peripheral vascular intervention)

Secondary outcomes

  1. Per procedural pain.

    Per procedural pain, measured by the visual analog pain scale. The visual analog pain scale rates pain from 0 to 10, 0 being the least pain imaginable and 10 the maximal pain imaginable.

    Time frame: Day 1 (Immediately after the peripheral vascular intervention)

  2. Remembered per procedural anxiety.

    Remembered per procedural anxiety measured by the Spielberg Anxiety State Inventory in French (Gauthier and Bouchard, 1993). The Spielberger Anxiety State Inventory is a self questionnaire of 20 items, each item scores from 1 to 4. The result of the test is the sum of the 20 items, therefore the result ranges from 20 to 80. A high score is related to a high level of anxiety at the moment of the test.

    Time frame: 3 months

  3. Remembered per procedural pain.

    Remembered per procedural pain will be measured by the visual analog pain scale. The visual analog pain scale rates pain from 0 to 10, 0 being the least pain imaginable and 10 the maximal pain imaginable.

    Time frame: 3 months

  4. Adverse events

    Device deficiencies

    Time frame: Day 1

  5. Serious adverse events

    Amputation, mesenteric or renal ischemia, and death

    Time frame: Day 90

07

Study locations

1 site
  • CHUV
    Lausanne, Vaud 1011, Switzerland
08

References and documents

Publications

  • Qanadli SD, Gudmundsson L, Gullo G, Ponti A, Saltiel S, Jouannic AM, Faouzi M, Rotzinger DC. Virtually Augmented Self-Hypnosis applied to endovascular interventions (VA-HYPO): Randomized Controlled Trial Protocol. PLoS One. 2022 Feb 23;17(2):e0263002. doi: 10.1371/journal.pone.0263002. eCollection 2022. PubMed 35196310 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 30, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04561596
Lead sponsor
Salah D. Qanadli, MD, PhD
Responsible party
Salah D. Qanadli, MD, PhD (Professor, University of Lausanne) — Sponsor-investigator
First posted
Sep 23, 2020
Start date
Sep 23, 2020
Primary completion
Oct 5, 2020
Completion
Aug 31, 2022
Last update
Sep 30, 2022

Study contacts

Salah Dine Qanadli, Prof. MD PhD
study director · Unil, CHUV

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion